Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity - EUR (€) |
Shares outstanding |
Issued capital |
Share premium |
Other capital reserves |
Accumulated deficit |
Other components of equity |
Total |
---|---|---|---|---|---|---|---|
Balance at Dec. 31, 2023 | € 7,065,993 | € 334,211,338 | € 40,050,053 | € (286,127,819) | € 7,382,166 | € 102,581,730 | |
Balance (in Shares) at Dec. 31, 2023 | 58,883,272 | ||||||
Loss for the period | (23,502,977) | (23,502,977) | |||||
Exchange differences on translation of foreign currency | 0 | 2,836 | 2,836 | ||||
Total comprehensive loss | (23,502,977) | 2,836 | (23,500,141) | ||||
Equity-settled share-based payments | 3,073,814 | 3,073,814 | |||||
Balance at Jun. 30, 2024 | 7,065,993 | 334,211,338 | 43,123,867 | (309,630,796) | 7,385,002 | 82,155,403 | |
Balance (in Shares) at Jun. 30, 2024 | 58,883,272 | ||||||
Balance at Dec. 31, 2024 | 7,122,205 | 334,929,685 | 44,115,861 | (332,192,221) | 7,440,510 | 61,416,039 | |
Balance (in Shares) at Dec. 31, 2024 | 59,351,710 | ||||||
Loss for the period | (22,730,298) | (22,730,298) | |||||
Exchange differences on translation of foreign currency | (264,271) | (264,271) | |||||
Total comprehensive loss | (22,730,298) | (264,271) | (22,994,569) | ||||
Issuance of ordinary shares | 1,007,450 | 15,136,235 | 16,143,686 | ||||
Issuance of ordinary shares (in Shares) | 8,395,420 | ||||||
Transaction costs for ordinary shares | (1,109,305) | (1,109,305) | |||||
Equity-settled share-based payments | 3,588,514 | 3,588,514 | |||||
Balance at Jun. 30, 2025 | € 8,129,656 | € 348,956,615 | € 47,704,375 | € (354,922,519) | € 7,176,239 | € 57,044,365 | |
Balance (in Shares) at Jun. 30, 2025 | 67,747,130 |
X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The increase in equity through the issue of equity instruments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|